RetInSight Fluid Monitor
The RetInSight Fluid Monitor for Neovascular Age-Related Macular Degeneration (nAMD)
From subjective to objective evaluation: Quantify fluid dynamics in nAMD
Key features of the RetInSight Fluid Monitor
- Precise visualization: Visualize the most important retinal fluid types and location automatically and at one glance
- Accurate fluid measurement: Accurately measure fluid-related biomarkers such as intraretinal fluid (IRF), subretinal fluid (SRF) and pigment epithelial detachment (PED) in nanoliters in real-time1 2 – with IRF being crucial for risk of aggressive disease and predicting significant vision loss over time3
- Dynamic follow-up charts: Generate follow-up charts of fluid dynamics for an individual overview of the recurrence profile
- Disease progression visualization: Visualize disease progression over time, enabling improved disease management
- Regulatory compliance: The RetInSight Fluid Monitor meets all MDR 2017/745 requirements for Class IIa medical devices, ensuring it adheres to the highest standards of quality and safety
Why the RetInSight Fluid Monitor is a game-changer in nAMD management
Looking for a more efficient way to detect pathological fluid in your patients’ OCTs?
- Objective evaluation: Move from subjective to objective evaluation with the ability to automatically quantify fluid in nAMD
- Follow-up function: Generate a follow-up chart of fluid dynamics to track individual recurrence profiles and visualize disease progression over time, facilitating disease management
- Efficient workflow: Integrate nAMD management seamlessly into your current optical coherence tomography (OCT) routine, streamlining workflow and enhancing efficiency
- Quality control: Replace time-consuming and error-prone manual retinal image analysis with fast, reproducible, and quantifiable real-time data
- Patient communication: Foster patient compliance by delivering customized, real-time reports to patients increasing trust with self-explanatory, personalized reports
Real-time visualization supporting robust diagnostic decisions in nAMD care
As a trusted leader in retinal care, RetInSight invites you to explore the Fluid Monitor and experience the next generation of nAMD management. Our innovative technology will empower you to make informed treatment decisions based on precise measurements and visualizations of fluid-related biomarkers.
The RetInSight Fluid Monitor meets all MDR 2017/745 requirements for Class IIa medical devices as Clinical Decision Support Systems (CDSS) for the monitoring of patients with nAMD, ensuring its adherence to the highest standards of quality and safety.
For more information and a demo of the RetInSight Fluid Monitor, please get in touch with our team. Together, let’s revolutionize the way we manage and treat wet AMD.
References
- Bianca Gerendas S. et al. | Validation of an automated fluid algorithm on real-world data of neovascular age-related macular degeneration over five years
- Gregor S. Reiter et al. | Performance of an Artificial Intelligence Decision Support Tool, the Vienna Fluid Monitor in Neovascular Age-Related Macular Degeneration. Presentation at Euretina 2022.
- Gregor S. Reiter et al. | Long-term effect of fluid volumes during the maintenance phase in neovascular age-related macular degeneration in the real world: results from Fight Retinal Blindness!